DOCTOR PROFILE
About Dr. Christine Leduc, Pharm. D.
Dr. Christine Leduc, Pharm. D. was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening.
Articles by Dr. Christine Leduc, Pharm. D.
IVIG for Infertility: Is This Treatment Right for You?
The use of IVIG for infertility and in vitro fertilization (IVF) failure is common in the U.S., unlike in other developed nations. So, what makes IVIG so attractive? This article explains when IVIG may be an option for infertility. You will also learn about IVIG success rates, potential side effects, and treatment cost.
TPN and Lipids: Nourishing the Body Beyond Energy
Lipids are more than just the source of energy in TPN (Total Parenteral Nutrition). They also help regulate immunity, inflammation, and liver health. Most of us probably know lipids (or simply fats) as calorie-dense macronutrients responsible for providing energy to the body.
Intravenous (IV) fat products have the potential for use in several medical conditions as well as improving treatment outcomes.
Kisqali: A First-Line Treatment Option for Breast Cancer
Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. Kisqali is considered the first-line treatment option. It is also effective in extending survival when combined with hormone therapy. Novartis, a Swiss multinational pharmaceutical company, developed Kisqali. It works by blocking specific enzymes that promote cancer cell division.
Guillain-Barre Syndrome Risk Factors
This article discusses the established as well as emerging Guillain-Barre syndrome risk factors. Guillain-Barre syndrome is a rare condition, affecting 3,000 to 6,000 Americans each year. (1) It causes your immune system to attack your peripheral nerves. Hence, it can be considered an autoimmune disorder. The affected nerves control muscle movement and sensations of touch and pain. GBS can lead to:
Onivyde: Offering Hope in Metastatic Pancreatic Cancer Treatment
Metastatic pancreatic cancer is a devastating disease with a low survival rate. However, there’s a promising chemotherapy drug for this condition — Onivyde (irinotecan liposome injection). It is used in combination with other chemotherapy medications to manage the targeted cancer. Onivyde targets the enzyme topoisomerase I, which is essential for DNA replication in cancer cells. Its liposomal encapsulation helps to target cancer cells and reduce the reactions associated with the therapy. However, patients should be aware of the potential side effects of Onivyde and work closely with their healthcare provider to manage any symptoms.
A Complete Guide to TPN Therapy
Your body needs a certain balance of nutrients and fluids to function properly. Inadequate nutrition can impair your health, causing hormonal imbalances and a compromised immune system, among many other disorders.